Brosmed receives CE mark approval for Pronavi™ Microcatheter
Release time:
2021-05-26
Sittard, Netherlands [May 26, 2021] –Brosmed, a medical device company developing and commercializing innovative interventional treatment systems for patients with coronary and peripheral disease today announced she received CE Mark approval in the European Union for its Pronavi™ Microcatheter .Device is indicated for use in both coronary and peripheral interventions.
Sittard, Netherlands [May 26, 2021] –Brosmed, a medical device company developing and commercializing innovative interventional treatment systems for patients with coronary and peripheral disease today announced she received CE Mark approval in the European Union for its Pronavi™ Microcatheter .Device is indicated for use in both coronary and peripheral interventions.
Microcatheters are used to provide support and safe guidewire exchange during complex cardiovascular procedures. The Pronavi™ Microcatheter facilitates excellent guidewire support, guidewire exchange and focal delivery of contrast media into coronary arteries, peripheral and abdominal vascular systems during complex endovascular procedures.
The Pronavi™ microcatheter has two kinds of distal tip design – a 1.7Fr & 1.9 Fr. The Pronavi™ 1.7Fr, has a proprietary hydrophilic coating and flexible distal segment to enable advancement and access through distal tortuous vessels. The shaft is fully stainless-steel braided for responsiveness, lumen integrity, and pushability. The radiopaque tapered soft 1.9Fr tip provides exceptional durability and pushability through tight calcified lesions and interstitial branches.
Pronavi™ is 0.014” guidewire compatible and available in 135cm,150cm and162cm lengths. 6 configurations in total for antegrade and retrograde access . 135 cm working length is used for antegrade; 150 cm and 162cm for retrograde .
“We are delighted to expand our CTO portfolio to include microcatheters for complex coronary and peripheral interventions.”said David Camp Business development VP of Brosmed .“We are committed to delivering innovative products that can change the lives of patients and their families around the world and to provide our physician partners with a greater flexibility and treatment options for patients.”
About BrosMed Medical
BrosMed Medical develops, manufactures and markets medical devices primarily used by interventional cardiologists, radiologists and vascular surgeons in angioplasty procedures and other minimal invasive devices.
We provide solutions to our customers through innovative design, effective supply chain management, world-class manufacturing, and flexible channels of distribution and through the development or acquisition of innovative technologies.
Join with Us!
Please fill out this form and we will get in touch within 24 hours.
* Note: Please be sure to fill in the information accurately and keep the communication unblocked. We will get in touch with you as soon as possible.
More news
BrosMed Announced CE MDR Approval of New Generation Conger™ Plus Hydrophilic Guidewires
Designed for superior crossability and maneuverability in peripheral interventions, Conger Plus now offers 116 models with expanded sizes (OD 0.018'' to 0.038'') and lengths (up to 300cm).
2025-04-25
Meet BrosMed at ESC Congress 2024
BrosMed Medical is delighted to participate in the ESC Congress 2024 from August 30th to September 2nd in London, UK.
2024-08-15
BrosMed Medical Announces Scott J. Addonizio as Chief Operating Officer
2024 August 1st – BrosMed Medical is pleased to announce the appointment of Scott J. Addonizio as its Chief Operating Officer (COO), effective immediately. Mr. Scott J. Addonizio brings a wealth of experience and expertise to BrosMed, with a distinguished career spanning almost 30 years in the medical device industry. Prior to joining BrosMed, Mr. Addonizio served as SVP at Cordis and COO at MedAlliance Swiss Medical Technology.
2024-08-01
CTO&CHIP PCI – Insights from the clinical practice (Ⅱ)
July 30, 2024 @16:00-17:30 (Beijing Time) Join BrosMed Medical on Tuesday, July 30 for an enlightening discussion that unites cardiologists from Malaysia, China, India, Tunisia and Portugal, where clinical expertise harmoniously fuses with CTO&CHIP innovation. At this exclusive webinar, we’re orchestrating a confluence of valuable insights, drawing from the collective wisdom of seasoned interventional cardiologists.
2024-07-26
BrosMed Announced CE MDR Approval of New Generation PTA SC Balloon Dilatation Catheters
May 27, 2024- BrosMed announced that it receives European Medical Device Regulation (MDR) certification for the New Generation PTA SC Balloon Dilatation Catheters (Brand Name: Polux™ Pro 014, Minerva™ Pro 018 and Atropos™ Pro 035).
2024-05-27